Abstract

Background

Multiple sclerosis (MS) is an inflammatory demyelinating central nervous system disease with diverse clinical manifestations. The present study aimed to compare the psychiatric outcomes of MS patients with full ambulatory versus impaired ambulatory function and identify the potential risk factors for disability in MS. Seventy MS patients were classified into two groups based on their Expanded Disability Status Scale (EDSS) scores, Group A: full ambulatory (EDSS ≤ 4.5) (N = 48), Group B: impaired ambulatory (EDSS ≥ 5) (N = 22). All participants were evaluated by the Socioeconomic Scale, Hamilton Anxiety Scale, Hamilton Depression Scale, Brief Psychiatric Rating Scale, and The Pittsburgh Sleep Quality Index.

Results

In the total cohort (N = 70), females represented (77.1%). The mean age was 31.16 ± 6.46, the mean age of onset was 26 ± 6.083, and the mean disease duration was 5.33 ± 3.653 years which was less in Group A than in Group B. Relapsing–remitting multiple sclerosis (RRMS) was the most common presentation (80%), representing 93.6% of Group A. Group A reported more severe depression and anxiety, while Group B had more poor sleep quality. Correlation analysis showed increased relapses, progressive-relapsing multiple sclerosis (PRMS), cervical or dorsal plaques, sensory or motor manifestations, and precipitancy increased disability, while RRMS type decreased disability.

Conclusions

Full ambulatory MS patients had high anxiety and depression, while impaired ambulatory MS patients had poor sleep quality. Associated factors for disability were frequent relapses, plaque location, MS subtype, sphincter, and sensory symptoms.

Trial registration clinicaltrials.gov, NCT05029830. Registered: September 01, 2021, https://clinicaltrials.gov/ct2/show/NCT05029830

Details

Title
Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants
Author
Hassan, Shady Safwat 1 ; Darwish, Esam S. 1 ; Ahmed, Gellan K. 2 ; Azmy, Samah R. 1 ; Haridy, Nourelhoda A. 3   VIAFID ORCID Logo 

 Assiut University Hospitals, Department of Neurology and Psychiatry, Faculty of Medicine, Assiut, Egypt (GRID:grid.411437.4) (ISNI:0000 0004 0621 6144) 
 Assiut University Hospitals, Department of Neurology and Psychiatry, Faculty of Medicine, Assiut, Egypt (GRID:grid.411437.4) (ISNI:0000 0004 0621 6144); King’s College London, Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
 Assiut University Hospitals, Department of Neurology and Psychiatry, Faculty of Medicine, Assiut, Egypt (GRID:grid.411437.4) (ISNI:0000 0004 0621 6144); University College London, Department of Neuromuscular Disorders, Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
Pages
105
Publication year
2023
Publication date
Dec 2023
Publisher
Springer Nature B.V.
ISSN
11101083
e-ISSN
16878329
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2843976385
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.